Draft:Spectrumedics Medical
![]() | Draft article not currently submitted for review.
This is a draft Articles for creation (AfC) submission. It is not currently pending review. While there are no deadlines, abandoned drafts may be deleted after six months. To edit the draft click on the "Edit" tab at the top of the window. To be accepted, a draft should:
It is strongly discouraged to write about yourself, your business or employer. If you do so, you must declare it. Where to get help
How to improve a draft
You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article. Improving your odds of a speedy review To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags. Editor resources
Last edited by Qwerfjkl (bot) (talk | contribs) 5 months ago. (Update) |
Spectrumedics Medical
Overview
Spectrumedics Medical is a medical device company specializing in intravascular lithotripsy (IVL) technology for the treatment of coronary and peripheral artery diseases. The company focuses on developing innovative, minimally invasive solutions to address vascular calcification, improving patient outcomes in interventional cardiology and peripheral interventions.
History
Spectrumedics Medical was founded in 2019 with the mission to advance intravascular lithotripsy technology as a safe and effective alternative to traditional atherectomy devices and cutting balloons. The company has since expanded its market presence in Southeast Asia, Latin America, and other emerging markets through strategic partnerships and regulatory approvals.
Products
SONICO-CX
The SONICO-CX is Spectrumedics Medical’s flagship IVL catheter system, designed to deliver controlled shockwave pulses to break down calcified plaque in coronary arteries.
Key Features:
• Higher pulse count (120 pulses per catheter)
• Smaller crossing profile for easier lesion access
• Comprehensive size range for various vessel diameters
Regulatory Approvals & Market Expansion
• In 2025, SONICO-CX received regulatory approval from DIGEMID in Peru, marking a major milestone in Latin America.
• Previously, the device was approved by ARCSA in Ecuador, with ongoing regulatory processes in other Latin American and Southeast Asian markets.
• The company is actively working towards approvals in major healthcare markets, including the European Union and the United States.
Research & Clinical Applications
Spectrumedics Medical collaborates with leading cardiovascular specialists and research institutions to advance the clinical understanding of IVL technology. The company participates in clinical trials, academic publications, and industry conferences such as TCT and EuroPCR to promote evidence-based adoption of IVL.